Filing metadata

Accession number
0001628280-23-032105
Form type
Form 3
Filer
Mirati Therapeutics, Inc.
CIK
CIK 1576263
Filed
Sep 12, 2023
Reporting period
Sep 08, 2023
Description
Initial ownership

Explore SEC Filings Hub